We've found
184,457
clinical trials
Dry Eye Clinical Trial
Study of EBI-005 in Dry Eye Disease (DED)
Status: Enrolling,
Phase
III
Updated: 4/7/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Nephropathies Clinical Trial
Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL)
Status: Enrolling,
Phase
II, III
Updated: 1/17/2016
Click here to add this to my saved trials
Long QT Syndrome Clinical Trial
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function
Status: Enrolling,
Phase
I
Updated: 2/5/2016
Click here to add this to my saved trials
Long QT Syndrome Clinical Trial
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function
Status: Enrolling,
Phase
I
Updated: 2/5/2016
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
Status: Enrolling,
Phase
II
Updated: 2/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
Status: Enrolling,
Phase
II
Updated: 2/2/2018
Click here to add this to my saved trials
Pyoderma Gangrenosum Clinical Trial
An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
Status: Enrolling,
Phase
III
Updated: 11/9/2015
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Gout Clinical Trial
DECT Study in Allopurinol-Treated Gout Patients
Status: Enrolling
Updated: 1/26/2016
Click here to add this to my saved trials
Gout Clinical Trial
DECT Study in Allopurinol-Treated Gout Patients
Status: Enrolling
Updated: 1/26/2016
Click here to add this to my saved trials
Gout Clinical Trial
DECT Study in Allopurinol-Treated Gout Patients
Status: Enrolling
Updated: 1/26/2016
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 1/21/2016
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 1/21/2016
Click here to add this to my saved trials
Epilepsy Clinical Trial
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis
Status: Enrolling
Updated: 1/26/2018
Click here to add this to my saved trials
Glioblastoma Clinical Trial
Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
Status: Enrolling,
Phase
I, II
Updated: 2/23/2016
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Respiratory Motion-Corrected Cone-Beam CT and Intratreatment Gating Based on Electromagnetic Transponders to Reduce Target Position Uncertainty in Radiation Treatment of Lung Malignancies
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
de Quervain's Disease Clinical Trial
Effectiveness of Astym Treatment For de Quervain's Tenosynovitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) Clinical Trial
Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Physician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
We've found
184,457
clinical trials
Dry Eye Clinical Trial
Updated: 4/7/2015
Study of EBI-005 in Dry Eye Disease (DED)
Status: Enrolling,
Phase
III
Updated: 4/7/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Nephropathies Clinical Trial
Updated: 1/17/2016
Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL)
Status: Enrolling,
Phase
II, III
Updated: 1/17/2016
Click here to add this to my saved trials
Long QT Syndrome Clinical Trial
Updated: 2/5/2016
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function
Status: Enrolling,
Phase
I
Updated: 2/5/2016
Click here to add this to my saved trials
Long QT Syndrome Clinical Trial
Updated: 2/5/2016
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function
Status: Enrolling,
Phase
I
Updated: 2/5/2016
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Updated: 12/31/1969
Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Updated: 12/31/1969
Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Updated: 12/31/1969
Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Updated: 12/14/2017
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2018
A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
Status: Enrolling,
Phase
II
Updated: 2/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 2/2/2018
A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
Status: Enrolling,
Phase
II
Updated: 2/2/2018
Click here to add this to my saved trials
Pyoderma Gangrenosum Clinical Trial
Updated: 11/9/2015
An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
Status: Enrolling,
Phase
III
Updated: 11/9/2015
Click here to add this to my saved trials
Clinical Trial
Updated: 12/7/2016
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
Updated: 12/7/2016
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
Updated: 12/7/2016
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
Updated: 12/7/2016
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
Updated: 12/7/2016
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
Updated: 12/7/2016
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
Updated: 12/7/2016
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
Updated: 12/7/2016
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
Updated: 12/7/2016
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
Updated: 12/7/2016
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Clinical Trial
Updated: 12/7/2016
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
Gout Clinical Trial
Updated: 1/26/2016
DECT Study in Allopurinol-Treated Gout Patients
Status: Enrolling
Updated: 1/26/2016
Click here to add this to my saved trials
Gout Clinical Trial
Updated: 1/26/2016
DECT Study in Allopurinol-Treated Gout Patients
Status: Enrolling
Updated: 1/26/2016
Click here to add this to my saved trials
Gout Clinical Trial
Updated: 1/26/2016
DECT Study in Allopurinol-Treated Gout Patients
Status: Enrolling
Updated: 1/26/2016
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Updated: 1/21/2016
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 1/21/2016
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Updated: 1/21/2016
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling,
Phase
II
Updated: 1/21/2016
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 2/26/2016
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
II
Updated: 2/26/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 1/26/2018
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis
Status: Enrolling
Updated: 1/26/2018
Click here to add this to my saved trials
Glioblastoma Clinical Trial
Updated: 2/23/2016
Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
Status: Enrolling,
Phase
I, II
Updated: 2/23/2016
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
Respiratory Motion-Corrected Cone-Beam CT and Intratreatment Gating Based on Electromagnetic Transponders to Reduce Target Position Uncertainty in Radiation Treatment of Lung Malignancies
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
de Quervain's Disease Clinical Trial
Updated: 12/31/1969
Effectiveness of Astym Treatment For de Quervain's Tenosynovitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Updated: 12/31/1969
Physician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Contraception Clinical Trial
Updated: 3/19/2016
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Updated: 3/19/2016
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Updated: 3/19/2016
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Updated: 3/19/2016
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Updated: 3/19/2016
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Updated: 3/19/2016
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Updated: 3/19/2016
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Updated: 3/19/2016
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Updated: 3/19/2016
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Updated: 3/19/2016
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Updated: 3/19/2016
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials
Contraception Clinical Trial
Updated: 3/19/2016
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Status: Enrolling,
Phase
III
Updated: 3/19/2016
Click here to add this to my saved trials